Acadia Pharmaceuticals (ACAD) Stock: Here’s What You Need To Know!

Acadia Pharmaceuticals (NASDAQ:ACAD) On Monday, Acadia Pharmaceuticals announced that it had initiated a phase 2 trial in patients with Alzheimer’s Disease Agitation. Once again ACAD will use its drug Pimavanserin to see if the drug will work in this targeted indication. The company has already received FDA approval for Pimavanserin in Parkinson’s Disease Psychosis. Now … Read more

ACADIA Pharmaceuticals (ACAD) Stock: Surges On Takeover Chatter; Value Of NUPLAZID

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceutics surged about 6% higher as investors revived the takeover chatter, citing the usual “unconfirmed sources” and tossing the $60.00 dollar a share acquisition price as a likely number that can seal a deal. The interested suitor is presumed to be Biogen (BIIB) with an outside chance Pfizer might … Read more

ACADIA Pharmaceuticals (ACAD) Stock: Gaining Big On Takeover Rumors

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Just minutes ago, ACADIA Pharmaceuticals started spiking in a big way. After a little searching through the grapevine, the CNA Finance team has uncovered a reason for the gains. Here’s what’s happening, why it’s happening, and what we can expect to see next from ACAD. Trade smarter and make more … Read more

ACADIA Pharmaceuticals (ACAD) Stock: Here’s Why It’s Up!

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals is having an incredible day in the market today, and for good reason. Late Friday, the company announced positive news it had received from the FDA. One of the treatments the company has been working on has been approved. Today, we’ll talk about that treatment, how the market … Read more

ACADIA Pharmaceuticals (ACAD) Stock: Here’s Why We’re Seeing Gains

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals is having an incredible time in the market at the moment, and for good reason. The company recently announced incredibly positive news with regard to a treatment for Parkinson’s Disease Psychosis that it has been working on for some time now. Today, we’ll talk about the news, how … Read more

ACADIA Pharmaceuticals (ACAD) Climbs On NDA Acceptance

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ACADIA Pharmaceuticals is having an incredible day in the market today after announcing that the United States Food and Drug Administration has accepted the review of its new drug application for its leading candidate for the treatment of psychosis associated with Parkinson’s disease. Today, we’ll talk about the treatment and … Read more

Biotech Stocks To Watch | Celgene Corporation (CELG) | Acadia Pharmaceuticals (ACAD) | Gilead Sciences (GILD) | MannKind Corporation (MNKD) | Zogenix (ZGNX)

Celgene Corporation Climbs After Acquisition Celgene Corporation (NASDAQ: CELG) Celgene Corporation stock is up in a big way today after the company announced after hours Tuesday that it had acquired Receptos (RCPT). The deal was valued at roughly $7.2 billion or $232 per share in cash. The goal of the acquisition of for CELG to … Read more

BioTech Stocks Are Starting To Recover | OREX | MNKD | ICPT

US stocks have had an incredibly rough time in the market this week. Mid last week, the Federal Reserve made a statement that they would not be aggressive in increasing interest rates. While the lack of aggression made investors happy short term, it seems as though reality set in early this week as the Dow … Read more

Biotech Stock News (ACAD) (CUR) (AMRN)

Acadia Pharmaceuticals (ACAD) Shares of Acadia Pharmaceuticals tanked around 30% in after hours trade on 3/11/15 after it had announced two different sets of news. The first set of news was that the CEO of Acadia Uli Hacksell would not only be stepping down as the CEO of the company but stepping down from the … Read more